| Financial Year |
March 31 2023 |
| Monetary Funds |
160,988,790.97 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
302,395,126.33 |
| Advances to Suppliers |
12,783,393.73 |
| Other Receivables |
2,376,204.94 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
550,361,863.42 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
476,392.67 |
| Total Current Assets |
1,104,263,644.20 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
451,473,446.34 |
| Under-construction Projects |
259,967,319.57 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
132,475,368.64 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
22,464,989.66 |
| Deferred Income Tax Assets |
22,133,221.19 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
911,250,268.58 |
| Total Assets |
2,015,513,912.78 |
| Short-Term Loans |
30,056,763.89 |
| Trading Financial liabilities |
-- |
| Notes Payable |
5,492,192.00 |
| Accounts Payable |
142,173,276.83 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
27,609,020.67 |
| Taxes Payable |
14,424,234.05 |
| Interest Payable |
-- |
| Dividend Payable |
323,242.50 |
| Other payables |
12,272,314.31 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,013,073.57 |
| Other Current Liabilities |
2,394,326.94 |
| Sub-Total of Current Liabilities |
280,019,377.40 |
| Long-term Loans |
35,299,784.08 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,439,428.21 |
| Deferred Income Tax Liabilities |
26,851,019.95 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
93,551,108.63 |
| Total Liabilities |
373,570,486.03 |
| Paid-In Capital(Or Share Stock) |
404,136,500.00 |
| Capital Surplus |
428,524,487.44 |
| Surplus Reserve |
44,450,328.54 |
| LESS:Treasury Stock |
11,062,068.50 |
| Undistributed Profits |
770,464,932.67 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,641,943,426.75 |
| Owner's Equity（Stockholder's Equity） |
1,641,943,426.75 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,015,513,912.78 |
